glp 1 receptor agonist agent Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Agonists: A Scoping Review GLP-1 Receptor Agonists in Neurodegeneration:

Always consult a healthcare professional before starting any treatment

doi: 10.3389/fcdhc.2025.1590530 Received 09 March 2025 Accepted 18 June 2025 Published 10 July 2025 Volume 6 - 2025 Edited by Angelo Maria Patti, University of Palermo, Italy Reviewed by Anapaula Sommer Vinagre, Federal University of Rio Grande do Sul, Brazil Jun Eguchi, Okayama University, Japan Updates Copyright 2025 Hammad, Zafar, Ullah, Faisal, Iftikhar, Waheed, Muzaffar, Ahmed, Ashraf, Zahid, Akhtar and Mahmmoud Fadelallah Eljack

Researchers compared carnitine with testosterone in men who were experiencing low libido, fatigue, and depression

Its benefit to the liver is likely more indirect